{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T23:53:38Z","timestamp":1652745218316},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00482-021-00554-5","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T13:03:03Z","timestamp":1621947783000},"page":"211-222","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Schmerzen bei multipler Sklerose und Neuromyelitis-optica-Spektrum-Erkrankungen"],"prefix":"10.1007","volume":"35","author":[{"given":"Hannah L.","family":"Pellkofer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"K\u00fcmpfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"issue":"3","key":"554_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.pain.2005.01.015","volume":"114","author":"KB Svendsen","year":"2005","unstructured":"Svendsen\u00a0KB, Jensen\u00a0TS, Hansen\u00a0HJ, Bach\u00a0FW (2005) Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 114(3):473\u2013481. https:\/\/doi.org\/10.1016\/j.pain.2005.01.015","journal-title":"Pain"},{"issue":"11","key":"554_CR2","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1001\/archneurol.2012.768","volume":"69","author":"P Qian","year":"2012","unstructured":"Qian\u00a0P, Lancia\u00a0S, Alvarez\u00a0E, Klawiter\u00a0EC, Cross\u00a0AH, Naismith\u00a0RT (2012) Association of neuromyelitis optica with severe and intractable pain. Arch Neurol 69(11):1482\u20131487. https:\/\/doi.org\/10.1001\/archneurol.2012.768","journal-title":"Arch Neurol"},{"issue":"8","key":"554_CR3","doi-asserted-by":"publisher","first-page":"e71500","DOI":"10.1371\/journal.pone.0071500","volume":"8","author":"HL Pellkofer","year":"2013","unstructured":"Pellkofer\u00a0HL, Havla\u00a0J, Hauer\u00a0D, Schelling\u00a0G, Azad\u00a0SC, Kuempfel\u00a0T, Magerl\u00a0W, Huge\u00a0V (2013) The major brain endocannabinoid 2\u2011AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica. PLoS ONE 8(8):e71500. https:\/\/doi.org\/10.1371\/journal.pone.0071500","journal-title":"PLoS ONE"},{"issue":"4","key":"554_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/j.pain.0000000000001767","volume":"161","author":"H Heitmann","year":"2020","unstructured":"Heitmann\u00a0H, Haller\u00a0B, Tiemann\u00a0L, M\u00fchlau\u00a0M, Berthele\u00a0A, T\u00f6lle\u00a0TR, Salmen\u00a0A, Ambrosius\u00a0B, Bayas\u00a0A, Asseyer\u00a0S, Hartung\u00a0HP, Heesen\u00a0C, Stangel\u00a0M, Wildemann\u00a0B, Haars\u00a0S, Groppa\u00a0S, Luessi\u00a0F, K\u00fcmpfel\u00a0T, Nischwitz\u00a0S, Meuth\u00a0SG, Klotz\u00a0L, Linker\u00a0RA, Zettl\u00a0UK, Ziemann\u00a0U, Tumani\u00a0H, Tackenberg\u00a0B, Zipp\u00a0F, Wiendl\u00a0H, Gold\u00a0R, Hemmer\u00a0B, Ploner\u00a0M, German Competence Network Multiple Sclerosis (KKNMS) (2020) Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study. Pain 161(4):787\u2013796. https:\/\/doi.org\/10.1097\/j.pain.0000000000001767","journal-title":"Pain"},{"key":"554_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14729","author":"S Asseyer","year":"2021","unstructured":"Asseyer\u00a0S, Henke\u00a0E, Trebst\u00a0C, H\u00fcmmert\u00a0MW, Wildemann\u00a0B, Jarius\u00a0S, Ringelstein\u00a0M, Aktas\u00a0O, Pawlitzki\u00a0M, Korsen\u00a0M, Klotz\u00a0L, Siebert\u00a0N, Ruprecht\u00a0K, Bellmann-Strobl\u00a0J, Wernecke\u00a0KD, H\u00e4u\u00dfler\u00a0V, Havla\u00a0J, Gahlen\u00a0A, Gold\u00a0R, Paul\u00a0F, Kleiter\u00a0I, Ayzenberg\u00a0I, Neuromyelitis Optica Study Group (2021) Pain, depression, and quality of life in adults with MOG-antibody-associated disease. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.14729","journal-title":"Eur J Neurol"},{"issue":"2","key":"554_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00415-012-6579-2","volume":"260","author":"A Truini","year":"2013","unstructured":"Truini\u00a0A, Barbanti\u00a0P, Pozzilli\u00a0C, Cruccu\u00a0G (2013) A mechanism-based classification of pain in multiple sclerosis. J\u00a0Neurol 260(2):351\u2013367. https:\/\/doi.org\/10.1007\/s00415-012-6579-2","journal-title":"J Neurol"},{"issue":"3","key":"554_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10072-017-3217-x","volume":"39","author":"D Ferraro","year":"2018","unstructured":"Ferraro\u00a0D, Plantone\u00a0D, Morselli\u00a0F, Dallari\u00a0G, Simone\u00a0AM, Vitetta\u00a0F, Sola\u00a0P, Primiano\u00a0G, Nociti\u00a0V, Pardini\u00a0M, Mirabella\u00a0M, Vollono\u00a0C (2018) Systematic assessment and characterization of chronic pain in multiple sclerosis patients. Neurol Sci 39(3):445\u2013453. https:\/\/doi.org\/10.1007\/s10072-017-3217-x","journal-title":"Neurol Sci"},{"issue":"11","key":"554_CR8","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1177\/1352458516643600","volume":"22","author":"S Otero-Romero","year":"2016","unstructured":"Otero-Romero\u00a0S, Sastre-Garriga\u00a0J, Comi\u00a0G, Hartung\u00a0HP, Soelberg S\u00f8rensen\u00a0P, Thompson\u00a0AJ, Vermersch\u00a0P, Gold\u00a0R, Montalban\u00a0X (2016) Pharmacological management of spasticity in multiple sclerosis: systematic review and consensus paper. Mult Scler 22(11):1386\u20131396. https:\/\/doi.org\/10.1177\/1352458516643600","journal-title":"Mult Scler"},{"issue":"12","key":"554_CR9","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1177\/1352458518799580","volume":"25","author":"PS Rommer","year":"2019","unstructured":"Rommer\u00a0PS, Eichst\u00e4dt\u00a0K, Ellenberger\u00a0D, Flachenecker\u00a0P, Friede\u00a0T, Haas\u00a0J, Kleinschnitz\u00a0C, P\u00f6hlau\u00a0D, Rienhoff\u00a0O, Stahmann\u00a0A, Zettl\u00a0UK (2019) Symptomatology and symptomatic treatment in multiple sclerosis: results from a\u00a0nationwide MS registry. Mult Scler 25(12):1641\u20131652. https:\/\/doi.org\/10.1177\/1352458518799580","journal-title":"Mult Scler"},{"issue":"8","key":"554_CR10","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1097\/j.pain.0000000000000492","volume":"157","author":"NB Finnerup","year":"2016","unstructured":"Finnerup\u00a0NB, Haroutounian\u00a0S, Kamerman\u00a0P, Baron\u00a0R, Bennett\u00a0DLH, Bouhassira\u00a0D, Cruccu\u00a0G, Freeman\u00a0R, Hansson\u00a0P, Nurmikko\u00a0T, Raja\u00a0SN, Rice\u00a0ASC, Serra\u00a0J, Smith\u00a0BH, Treede\u00a0RD, Jensen\u00a0TS (2016) Neuropathic pain: an updated grading system for research and clinical practice. Pain 157(8):1599\u20131606. https:\/\/doi.org\/10.1097\/j.pain.0000000000000492","journal-title":"Pain"},{"issue":"18","key":"554_CR11","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","volume":"70","author":"RD Treede","year":"2008","unstructured":"Treede\u00a0RD, Jensen\u00a0TS, Campbell\u00a0JN, Cruccu\u00a0G, Dostrovsky\u00a0JO, Griffin\u00a0JW, Hansson\u00a0P, Hughes\u00a0R, Nurmikko\u00a0T, Serra\u00a0J (2008) Neuropathic pain: redefinition and a\u00a0grading system for clinical and research purposes. Neurology 70(18):1630\u20131635. https:\/\/doi.org\/10.1212\/01.wnl.0000282763.29778.59","journal-title":"Neurology"},{"issue":"1","key":"554_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s10194-019-0969-0","volume":"20","author":"G Di Stefano","year":"2019","unstructured":"Di Stefano\u00a0G, Maarbjerg\u00a0S, Truini\u00a0A (2019) Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options. J\u00a0Headache Pain 20(1):20. https:\/\/doi.org\/10.1186\/s10194-019-0969-0","journal-title":"J Headache Pain"},{"issue":"5","key":"554_CR13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1212\/01.wnl.0000137047.85868.d6","volume":"63","author":"C Solaro","year":"2004","unstructured":"Solaro\u00a0C, Brichetto\u00a0G, Amato\u00a0MP, Cocco\u00a0E, Colombo\u00a0B, D\u2019Aleo\u00a0G, Gasperini\u00a0C, Ghezzi\u00a0A, Martinelli\u00a0V, Milanese\u00a0C, Patti\u00a0F, Trojano\u00a0M, Verdun\u00a0E, Mancardi\u00a0GL, PaIMS Study Group (2004) The prevalence of pain in multiple sclerosis: a\u00a0multicenter cross-sectional study. Neurology 63(5):919\u2013921. https:\/\/doi.org\/10.1212\/01.wnl.0000137047.85868.d6","journal-title":"Neurology"},{"issue":"10","key":"554_CR14","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1007\/s00115-020-00959-0","volume":"91","author":"M Gebhardt","year":"2020","unstructured":"Gebhardt\u00a0M, Kropp\u00a0P, Hoffmann\u00a0F, Zettl\u00a0UK (2020) Headache in multiple sclerosis. Nervenarzt 91(10):926\u2013935. https:\/\/doi.org\/10.1007\/s00115-020-00959-0","journal-title":"Nervenarzt"},{"issue":"9","key":"554_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrneurol.2014.129","volume":"10","author":"M Bradl","year":"2014","unstructured":"Bradl\u00a0M, Kanamori\u00a0Y, Nakashima\u00a0I, Misu\u00a0T, Fujihara\u00a0K, Lassmann\u00a0H, Sandk\u00fchler\u00a0J (2014) Pain in neuromyelitis optica\u2014prevalence, pathogenesis and therapy. Nat Rev Neurol 10(9):529\u2013536","journal-title":"Nat Rev Neurol"},{"key":"554_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jns.2016.06.041","volume":"368","author":"Y Kong","year":"2016","unstructured":"Kong\u00a0Y, Okoruwa\u00a0H, Revis\u00a0J, Tackley\u00a0G, Leite\u00a0MI, Lee\u00a0M, Tracey\u00a0I, Palace\u00a0J (2016) Pain in patients with transverse myelitis and its relationship to aquaporin 4 antibody status. J\u00a0Neurol Sci 368:84\u201388. https:\/\/doi.org\/10.1016\/j.jns.2016.06.041","journal-title":"J Neurol Sci"},{"key":"554_CR17","doi-asserted-by":"publisher","first-page":"101965","DOI":"10.1016\/j.msard.2020.101965","volume":"40","author":"S Asseyer","year":"2020","unstructured":"Asseyer\u00a0S, Hamblin\u00a0J, Messina\u00a0S, Mariano\u00a0R, Siebert\u00a0N, Everett\u00a0R, K\u00fcker\u00a0W, Bellmann-Strobl\u00a0J, Ruprecht\u00a0K, Jarius\u00a0S, Leite\u00a0MI, Brandt\u00a0A, Paul\u00a0F, Palace\u00a0J (2020) Prodromal headache in MOG-antibody positive optic neuritis. Mult Scler Relat Disord 40:101965. https:\/\/doi.org\/10.1016\/j.msard.2020.101965","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"554_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00415-008-0545-z","volume":"255","author":"M Nakamura","year":"2008","unstructured":"Nakamura\u00a0M, Miyazawa\u00a0I, Fujihara\u00a0K, Nakashima\u00a0I, Misu\u00a0T, Watanabe\u00a0S, Takahashi\u00a0T, Itoyama\u00a0Y (2008) Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study. J\u00a0Neurol 255(2):163\u2013170. https:\/\/doi.org\/10.1007\/s00415-008-0545-z","journal-title":"J Neurol"},{"issue":"13","key":"554_CR19","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1177\/0333102418764891","volume":"38","author":"LM Honningsv\u00e5g","year":"2018","unstructured":"Honningsv\u00e5g\u00a0LM, H\u00e5berg\u00a0AK, Hagen\u00a0K, Kvistad\u00a0KA, Stovner\u00a0LJ, Linde\u00a0M (2018) White matter hyperintensities and headache: a population-based imaging study (HUNT MRI). Cephalalgia 38(13):1927\u20131939","journal-title":"Cephalalgia"},{"issue":"6","key":"554_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1185\/03007995.2016.1157460","volume":"32","author":"R Freynhagen","year":"2016","unstructured":"Freynhagen\u00a0R, T\u00f6lle\u00a0TR, Gockel\u00a0U, Baron\u00a0R (2016) The painDETECT project\u2014far more than a\u00a0screening tool on neuropathic pain. Curr Med Res Opin 32(6):1033\u20131057. https:\/\/doi.org\/10.1185\/03007995.2016.1157460","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"554_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.apmr.2018.08.178","volume":"100","author":"T Demaneuf","year":"2019","unstructured":"Demaneuf\u00a0T, Aitken\u00a0Z, Karahalios\u00a0A, Leong\u00a0TI, De Livera\u00a0AM, Jelinek\u00a0GA, Weiland\u00a0TJ, Marck\u00a0CH (2019) Effectiveness of exercise interventions for pain reduction in people with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials. Arch Phys Med Rehabil 100(1):128\u2013139. https:\/\/doi.org\/10.1016\/j.apmr.2018.08.178","journal-title":"Arch Phys Med Rehabil"},{"issue":"12","key":"554_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11940-019-0601-2","volume":"21","author":"T Aboud","year":"2019","unstructured":"Aboud\u00a0T, Schuster\u00a0NM (2019) Pain management in multiple sclerosis: a\u00a0review of available treatment options. Curr Treat Options Neurol 21(12):62. https:\/\/doi.org\/10.1007\/s11940-019-0601-2","journal-title":"Curr Treat Options Neurol"},{"key":"554_CR23","doi-asserted-by":"publisher","first-page":"317859","DOI":"10.1155\/2015\/317859","volume":"2015","author":"GA Beiske","year":"2015","unstructured":"Beiske\u00a0GA, Holm\u00f8y\u00a0T, Beiske\u00a0AG, Johannessen\u00a0SI, Johannessen\u00a0Landmark C (2015) Antiepileptic and antidepressive polypharmacy in patients with multiple sclerosis. Mult Scler Int 2015:317859. https:\/\/doi.org\/10.1155\/2015\/317859","journal-title":"Mult Scler Int"},{"key":"554_CR24","series-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","volume-title":"Diagnose und nicht interventionelle Therapie neuropathischer Schmerzen, S2k-Leitlinie","author":"T Schlereth","year":"2019","unstructured":"Schlereth\u00a0T et al (2019) Diagnose und nicht interventionelle Therapie neuropathischer Schmerzen, S2k-Leitlinie. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Deutsche Gesellschaft f\u00fcr Neurologie, Berlin"},{"issue":"2","key":"554_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/00207454.2018.1481066","volume":"129","author":"J Markov\u00e0","year":"2019","unstructured":"Markov\u00e0\u00a0J, Essner\u00a0U, Akmaz\u00a0B, Marinelli\u00a0M, Trompke\u00a0C, Lentschat\u00a0A, Vila\u00a0C (2019) Sativex\u00ae as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a\u00a0double-blind, placebo-controlled randomised clinical trial. Int J Neurosci 129(2):119\u2013128. https:\/\/doi.org\/10.1080\/00207454.2018.1481066","journal-title":"Int J Neurosci"},{"issue":"10","key":"554_CR26","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s10072-020-04392-8","volume":"41","author":"M Moccia","year":"2020","unstructured":"Moccia\u00a0M, Frau\u00a0J, Carotenuto\u00a0A, Butera\u00a0C, Coghe\u00a0G, Barbero\u00a0P, Frontoni\u00a0M, Groppo\u00a0E, Giovannelli\u00a0M, Del Carro\u00a0U, Inglese\u00a0C, Frasson\u00a0E, Castagna\u00a0A, Buccafusca\u00a0M, Latino\u00a0P, Nascimbene\u00a0C, Romano\u00a0M, Liotti\u00a0V, Lanfranchi\u00a0S, Rapisarda\u00a0L, Lori\u00a0S, Esposito\u00a0M, Maggi\u00a0L, Petracca\u00a0M, Lo Fermo\u00a0S, Altavista\u00a0MC, Bono\u00a0F, Eleopra\u00a0R, Brescia Morra\u00a0V (2020) Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study. Neurol Sci 41(10):2781\u20132792. https:\/\/doi.org\/10.1007\/s10072-020-04392-8","journal-title":"Neurol Sci"},{"key":"554_CR27","doi-asserted-by":"publisher","first-page":"101461","DOI":"10.1016\/j.msard.2019.101461","volume":"37","author":"D Ferraro","year":"2020","unstructured":"Ferraro\u00a0D, Annovazzi\u00a0P, Moccia\u00a0M, Lanzillo\u00a0R, De Luca\u00a0G, Nociti\u00a0V, Fantozzi\u00a0R, Paolicelli\u00a0D, Ragonese\u00a0P, Gajofatto\u00a0A, Boffa\u00a0L, Cavalla\u00a0P, Lo Fermo\u00a0S, Buscarinu\u00a0MC, Lorefice\u00a0L, Cordioli\u00a0C, Calabrese\u00a0M, Gallo\u00a0A, Pinardi\u00a0F, Tortorella\u00a0C, Di Filippo\u00a0M, Camera\u00a0V, Maniscalco\u00a0GT, Radaelli\u00a0M, Buttari\u00a0F, Tomassini\u00a0V, Cocco\u00a0E, Gasperini\u00a0C, Solaro\u00a0C, RIREMS (Rising Researchers in Multiple Sclerosis) (2020) Characteristics and treatment of multiple sclerosis-related trigeminal neuralgia: an Italian multi-centre study. Mult Scler Relat Disord 37:101461. https:\/\/doi.org\/10.1016\/j.msard.2019.101461","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"554_CR28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00482-020-00496-4","volume":"34","author":"R Ruscheweyh","year":"2020","unstructured":"Ruscheweyh\u00a0R, Lutz\u00a0J, Mehrkens\u00a0JH (2020) Trigeminal neuralgia: modern diagnostic workup and treatment. Schmerz 34(6):486\u2013494. https:\/\/doi.org\/10.1007\/s00482-020-00496-4","journal-title":"Schmerz"},{"key":"554_CR29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.wneu.2017.04.102","volume":"103","author":"A Conti","year":"2017","unstructured":"Conti\u00a0A, Pontoriero\u00a0A, Iat\u00ec\u00a0G, Esposito\u00a0F, Siniscalchi\u00a0EN, Crimi\u00a0S, Vinci\u00a0S, Brogna\u00a0A, De Ponte\u00a0F, German\u00f2\u00a0A, Pergolizzi\u00a0S, Tomasello\u00a0F (2017) Frameless stereotactic radiosurgery for treatment of multiple sclerosis-related trigeminal neuralgia. World Neurosurg 103:702\u2013712. https:\/\/doi.org\/10.1016\/j.wneu.2017.04.102","journal-title":"World Neurosurg"},{"issue":"2","key":"554_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.7224\/1537-2073.2014-001","volume":"17","author":"TR Brown","year":"2015","unstructured":"Brown\u00a0TR, Slee\u00a0A (2015) A randomized placebo-controlled trial of duloxetine for central pain in multiple sclerosis. Int J MS Care 17(2):83\u201389. https:\/\/doi.org\/10.7224\/1537-2073.2014-001","journal-title":"Int J MS Care"},{"key":"554_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00482-020-00472-y","volume":"34","author":"W H\u00e4user","year":"2020","unstructured":"H\u00e4user\u00a0W (2020) 2. Aktualisierung der S3 Leitlinie \u201eLangzeitanwendungen von Opioiden bei chronischen nicht-tumorbedingten Schmerzen \u201aLONTS\u2018\u201c. Schmerz 34:204\u2013244","journal-title":"Schmerz"},{"issue":"1","key":"554_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1053\/eujp.2001.0307","volume":"6","author":"S Kalman","year":"2002","unstructured":"Kalman\u00a0S, Osterberg\u00a0A, S\u00f6rensen\u00a0J, Boivie\u00a0J, Bertler\u00a0A (2002) Morphine responsiveness in a\u00a0group of well-defined multiple sclerosis patients: a\u00a0study with i.v. morphine. Eur J Pain 6(1):69\u201380. https:\/\/doi.org\/10.1053\/eujp.2001.0307","journal-title":"Eur J Pain"},{"issue":"5\u20136","key":"554_CR33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000481089","volume":"78","author":"S Schimrigk","year":"2017","unstructured":"Schimrigk\u00a0S, Marziniak\u00a0M, Neubauer\u00a0C, Kugler\u00a0EM, Werner\u00a0G, Abramov-Sommariva\u00a0D (2017) Dronabinol is a\u00a0safe long-term treatment option for neuropathic pain patients. Eur Neurol 78(5\u20136):320\u2013329. https:\/\/doi.org\/10.1159\/000481089","journal-title":"Eur Neurol"},{"issue":"2021","key":"554_CR34","first-page":"2","volume":"10","author":"B Hemmer","year":"2021","unstructured":"Hemmer\u00a0B et al (2021) Diagnose und Therapie der Multiplen Sklerose, Neuromyelitis-optica-Spektrum-Erkrankungen und MOG-IgG-assoziierten Erkrankungen, S2k-Leitlinie. In: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg.), Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. www.dgn.org\/leitlinien. Zugegriffen: 10 Mai 2021","journal-title":"Therapie"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-021-00554-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-021-00554-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-021-00554-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T09:13:17Z","timestamp":1622106797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-021-00554-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1007\/s00482-021-00554-5","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"assertion":[{"value":"6 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>H.L.\u00a0Pellkofer:<\/b> A. Finanzielle Interessen: Honorar f\u00fcr\u00a0Vortragst\u00e4tigkeit\u00a0und Beratert\u00e4tigkeit: Roche Pharma, Biogen.\u00a0Die Zuwendung steht nicht in unmittelbarem Zusammenhang mit dem Thema des Artikels.  B. Nichtfinanzielle Interessen: Angestellte Neurologin, Ober\u00e4rztin, Institut f\u00fcr Klinische Neuroimmunologie des LMU Klinikums M\u00fcnchen, angestellte Lehrt\u00e4tigkeit an der staatlichen Berufsschule f\u00fcr Gesundheits- und Krankenpflege am LMU Klinikum. Mitglied der Neuromyelitis optica Studiengruppe (NEMOS).\u00a0<b>T.\u00a0K\u00fcmpfel:<\/b> A. Finanzielle Interessen: Unterst\u00fctzung f\u00fcr wissenschaftliche Projekte in Form geldwerter Leistungen f\u00fcr Personal und Forschungsmaterialien: Novartis, Chugai Pharma. \u2013\u00a0Finanzielle Unterst\u00fctzung f\u00fcr Vortragst\u00e4tigkeit: Bayer HealthCare, Teva Pharma, Merck, Novartis Pharma, Sanofi-Aventis\/Genzyme, CLB Behring, Roche Pharma, Biogen.\u00a0\u2013 B. Nichtfinanzielle Interessen: Angestellte Neurologin, leitende Ober\u00e4rztin, Institut f\u00fcr Klinische Neuroimmunologie, LMU Klinikum M\u00fcnchen | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Neurologie (DGN), Krankheitsbezogenes Kompetenznetz Multiple Sklerose (KKNMS), Deutsche Multiple Sklerose Gesellschaft (DMSG), Neuromyelitis optica Studiengruppe (NEMOS), German Network for Research on Autoimmune Encephalitis (GENERATE).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autorinnen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}